Literature DB >> 15608467

Significance of comorbidity for the long-term course of opiate dependence.

Uwe Verthein1, Peter Degkwitz, Christian Haasen, Michael Krausz.   

Abstract

OBJECTIVE: Studies on drug dependence show a high prevalence of comorbidity with additional mental disorders. Comorbidity patients also show more poly-substance use and other psychosocial problems. This study analyzed the importance of comorbidity for the long-term course of opiate dependence.
METHOD: 350 opiate-dependent patients were examined at yearly follow-ups over 4 years using the EuropASI for the assessment of drug-related problems and the CIDI for diagnostic of psychiatric disorders. 196 patients were reached at final follow up (56%).
RESULTS: Of the patients reached at final follow-up, 30% had severe, 29% mild and 41% no clinically relevant disorders at baseline. However, the linear relationship at baseline--the more severe the disorder, the greater the impairment through drug-related problems--was not present at final follow-up. The results show that lifetime diagnosis of mental disorder had no prognostic relevance for the long-term course of drug dependency.
CONCLUSION: The assumption that opiate users with an additional mental disorder are more vulnerable in their course of addiction could not be confirmed. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2005        PMID: 15608467     DOI: 10.1159/000081412

Source DB:  PubMed          Journal:  Eur Addict Res        ISSN: 1022-6877            Impact factor:   3.015


  9 in total

Review 1.  Quality of life as an outcome of opioid use disorder treatment: A systematic review.

Authors:  Jeremy W Bray; Brandon Aden; Ashley A Eggman; Leah Hellerstein; Eve Wittenberg; Bohdan Nosyk; Judy C Stribling; Bruce R Schackman
Journal:  J Subst Abuse Treat       Date:  2017-02-10

2.  The Readiness Ruler as a measure of readiness to change poly-drug use in drug abusers.

Authors:  Morten Hesse
Journal:  Harm Reduct J       Date:  2006-01-25

3.  Impact of comorbid psychiatric disorders on the outcome of substance abusers: a six year prospective follow-up in two Norwegian counties.

Authors:  Anne Signe Landheim; Kjell Bakken; Per Vaglum
Journal:  BMC Psychiatry       Date:  2006-10-20       Impact factor: 3.630

4.  Comorbid Psychopathology and Alcohol Use Patterns among Methadone Maintenance Treatment Patients.

Authors:  Georgios Moussas; Irene Fanouraki; Argiro Pachi; Arezina Asomatou; Olga Drylli; Georgios Paschalakis; Athanasios Tselebis; Konstantinos Giotakis; Dionisios Bratis; Georgios Dermatis; Meni Malliori
Journal:  J Addict       Date:  2015-03-23

5.  The impact of comorbid psychiatric disorders on methadone maintenance treatment in opioid use disorder: a prospective cohort study.

Authors:  Tea Rosic; Leen Naji; Monica Bawor; Brittany B Dennis; Carolyn Plater; David C Marsh; Lehana Thabane; Zainab Samaan
Journal:  Neuropsychiatr Dis Treat       Date:  2017-05-24       Impact factor: 2.570

6.  A cohort study evaluating the association between concurrent mental disorders, mortality, morbidity, and continuous treatment retention for patients in opioid agonist treatment (OAT) across Ontario, Canada, using administrative health data.

Authors:  Kristen A Morin; Joseph K Eibl; Graham Gauthier; Brian Rush; Christopher Mushquash; Nancy E Lightfoot; David C Marsh
Journal:  Harm Reduct J       Date:  2020-07-23

7.  Impact of co-occurring psychiatric disorders on retention in a methadone maintenance program: an 18-month follow-up study.

Authors:  Mònica Astals; Laura Díaz; Antònia Domingo-Salvany; Rocío Martín-Santos; Antoni Bulbena; Marta Torrens
Journal:  Int J Environ Res Public Health       Date:  2009-11-12       Impact factor: 3.390

8.  Axis I and II disorders as long-term predictors of mental distress: a six-year prospective follow-up of substance-dependent patients.

Authors:  Kjell Bakken; Anne Signe Landheim; Per Vaglum
Journal:  BMC Psychiatry       Date:  2007-06-26       Impact factor: 3.630

9.  Structural barriers in the context of opiate substitution treatment in Germany--a survey among physicians in primary care.

Authors:  Bernd Schulte; Christiane Sybille Schmidt; Olaf Kuhnigk; Ingo Schäfer; Benedikt Fischer; Heiner Wedemeyer; Jens Reimer
Journal:  Subst Abuse Treat Prev Policy       Date:  2013-07-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.